The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Oncology Devices Market From 2026 To 2030?
The oncology devices market size has recently experienced rapid expansion. It is forecast to grow from $177.72 billion in 2025 to $210.15 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 18.2%. Historically, this growth can be ascribed to a combination of increasing global cancer incidence rates, the expansion of hospital oncology departments, a growing demand for early diagnosis technologies, the availability of advanced imaging systems, and rising awareness of cancer screening programs.
The oncology devices market is anticipated to experience substantial expansion over the upcoming years. It is projected to reach **$397.27 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.3%.** This projected expansion is primarily driven by the increasing integration of personalized cancer treatment devices, rising financial commitments to oncology infrastructure, the broadening of outpatient cancer care facilities, the expanding application of AI-powered diagnostic instruments, and a heightened emphasis on precision oncology solutions. Key developments expected during this timeframe encompass the wider embrace of sophisticated cancer diagnostic equipment, the increased utilization of image-guided oncology therapies, the growing incorporation of minimally invasive cancer treatment technologies, the proliferation of precision radiation therapy apparatus, and a stronger focus on the early detection of cancer.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3373&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Oncology Devices Market?
The oncology devices market is anticipated to expand in the future, driven by the escalating need for chemotherapy. This cancer therapy employs potent medications to eliminate fast-multiplying cells, thereby inhibiting the progression and dissemination of tumors. The global increase in cancer cases is fueling the heightened demand for chemotherapy, as a greater number of diagnoses necessitates accessible and effective treatments capable of addressing various cancer forms and stages. Oncology devices play a crucial role in supporting chemotherapy, facilitating safer and more accurate drug administration and monitoring, which, in turn, improves treatment efficacy and patient results. For example, the U.S. National Cancer Institute, a U.S.-based federal cancer research agency, predicted that by January 2025, new cancer diagnoses in the United States would hit 2.04 million, an increase from 1.96 million in 2023, underscoring the expanding requirement for chemotherapy delivery systems. Consequently, the heightened need for chemotherapy is a significant factor in the expansion of the oncology devices market.
Which Segments Are Included In The Analysis Of The Oncology Devices Market?
The oncology devices market covered in this report is segmented –
1) By Device Type: Brachytherapy Devices, Endoscopic Devices
2) By Therapy: Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy
3) By End User: Hospitals, Cancer Research Institutes, Other End Users
Subsegments:
1) By Brachytherapy Devices: Afterloaders (High-Dose Rate (HDR) And Low-Dose Rate (LDR)), Applicators, Seeds, Accessories
2) By Endoscopic Devices: Endoscopes (Flexible, Rigid, Capsule), Endoscopic Ultrasound Systems, Endoscopic Accessories
Which Trends Are Impacting The Growth Of The Oncology Devices Market?
Leading companies in the oncology devices market are concentrating on developing sophisticated, precision-focused solutions aimed at elevating treatment precision, patient well-being, and operational efficiency within clinical environments. These innovations prioritize less invasive techniques, improved visual clarity, and dynamic therapy optimization to achieve superior outcomes across diverse cancer types. For instance, in April 2025, ZEISS, a Germany-based medical technology company, secured FDA 510(k) clearance for its INTRABEAM 700 system, which is a next-generation robotic-assisted intraoperative radiotherapy (IORT) platform engineered for precise radiation delivery in neuro-oncology and breast cancer procedures. The system boasts enhanced precision, optimized ergonomic design, and seamless integration into surgical workflows, empowering clinicians to administer localized radiation during operations while minimizing exposure to surrounding healthy tissues. By integrating cutting-edge imaging, robotics, and treatment planning functionalities, the INTRABEAM 700 boosts therapeutic accuracy, facilitates quicker clinical decision-making, and corresponds with the industry’s evolution towards technologically advanced, patient-centric oncology care.
Which Key Industry Participants Are Active In The Oncology Devices Market?
Major companies operating in the oncology devices market are Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic plc, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.
Read the full oncology devices market report here:
https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report
What Are The Leading Geographic Regions In The Oncology Devices Market?
North America was the largest region in the oncology devices market in 2025. Asia-Pacific was the second-largest region in the oncology devices market report. The regions covered in the oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Oncology Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=3373&type=smp
Browse Through More Reports Similar to the Global Oncology Devices Market 2026, By The Business Research Company
Interventional Oncology Devices Market Report 2026
Oncology Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market
Oncology Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/oncology-drugs-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model